Summary
GlobalData’s new report, "Germany Cardiac Rhythm
Management Devices Market Outlook to 2021", provides key market data on
the Germany Cardiac Rhythm Management Devices market. The report provides
value, in millions of US dollars, volume (in units) and average price data (in
US dollars), within market segments - Cardiac Resynchronisation Therapy (CRT),
Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR)
and Pacemakers. In the past few decades, the use of cardiac rhythm management
(CRM) devices has increased worldwide due to the increase in life expectancy
and technological developments (e.g., cardiac resynchronization therapy) that
have extended their indications (1,2,3,4). The report also provides company
shares and distribution shares data for the market category, and global
corporate-level profiles of the key market participants. Based on the
availability of data for the particular category and country, information
related to pipeline products, news and deals is available in the report.
Complete report details @
The data in the report is derived from dynamic market
forecast models. GlobalData uses epidemiology and capital equipment-based
models to estimate and forecast the market size. The objective is to provide
information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of
epidemiology data gathered from research publications and primary interviews
with physicians to establish the target patient population and treatment flow
patterns for individual diseases and therapies. Using prevalence and incidence
data and diagnosed and treated population, the epidemiology-based forecasting
model arrives at the final numbers.
Capital equipment-based forecasting models are done based
on the installed base, replacements and new sales of a specific
device/equipment in healthcare facilities such as hospitals, clinics and
diagnostic centers. Data for average number of units per facility is used to
arrive at the installed base of the capital equipment. Sales for a particular
year are arrived at by calculating the replacement units and new units
(additional and first-time purchases).
Extensive interviews are conducted with key opinion
leaders (KOLs), physicians and industry experts to validate the market size,
company share and distribution share data and analysis.
Request a sample report @ https://www.wiseguyreports.com/sample_request/417107/germany-cardiac-rhythm-management-devices-market-outlook
Scope
- Market size for Cardiac Rhythm Management Devices
market segments - Cardiac Resynchronisation Therapy (CRT), Implantable
Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and
Pacemakers.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Cardiac Rhythm Management Devices market.
- Global corporate-level profiles of key companies operating within the Germany Cardiac Rhythm Management Devices market.
- Key players covered include Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG and Others.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Cardiac Rhythm Management Devices market.
- Global corporate-level profiles of key companies operating within the Germany Cardiac Rhythm Management Devices market.
- Key players covered include Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG and Others.
Reasons to buy
- Develop business strategies by identifying the key
market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Make an enquiry before buying this
Report @ https://www.wiseguyreports.com/enquiry/417107/germany-cardiac-rhythm-management-devices-market-outlook
Table of
Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Cardiac Rhythm Management Devices Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Cardiac Rhythm Management Devices Market, Germany 9
3.1 Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), 2007-2014 9
3.2 Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), 2014-2021 11
3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Revenue ($m), by Segment, 2007-2014 13
3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Revenue ($m), by Segment, 2007-2014 15
3.2.3 Pacemakers Market, Germany, Revenue ($m), by Segment, 2007-2014 17
3.2.4 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Revenue ($m), by Segment, 2014-2021 19
3.2.5 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Revenue ($m), by Segment, 2014-2021 21
3.2.6 Pacemakers Market, Germany, Revenue ($m), by Segment, 2014-2021 23
3.3 Cardiac Rhythm Management Devices Market, Germany, Volume (Units), 2007-2014 25
3.4 Cardiac Rhythm Management Devices Market, Germany, Volume (Units), 2014-2021 27
3.4.1 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Volume (Units), by Segment, 2007-2014 29
3.4.2 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Volume (Units), by Segment, 2007-2014 31
3.4.3 Pacemakers Market, Germany, Volume (Units), by Segment, 2007-2014 33
3.4.4 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Volume (Units), by Segment, 2014-2021 35
3.4.5 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Volume (Units), by Segment, 2014-2021 37
3.4.6 Pacemakers Market, Germany, Volume (Units), by Segment, 2014-2021 39
3.5 Cardiac Rhythm Management Devices Market, Germany, Average Price ($), 2007-2021 41
3.6 Cardiac Rhythm Management Devices Market, Germany, Distribution Share by Revenue ($m), 2013-2014 43
3.7 Cardiac Rhythm Management Devices Market, Germany, Company Share by Revenue ($m), 2014 44
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Cardiac Rhythm Management Devices Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Cardiac Rhythm Management Devices Market, Germany 9
3.1 Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), 2007-2014 9
3.2 Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), 2014-2021 11
3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Revenue ($m), by Segment, 2007-2014 13
3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Revenue ($m), by Segment, 2007-2014 15
3.2.3 Pacemakers Market, Germany, Revenue ($m), by Segment, 2007-2014 17
3.2.4 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Revenue ($m), by Segment, 2014-2021 19
3.2.5 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Revenue ($m), by Segment, 2014-2021 21
3.2.6 Pacemakers Market, Germany, Revenue ($m), by Segment, 2014-2021 23
3.3 Cardiac Rhythm Management Devices Market, Germany, Volume (Units), 2007-2014 25
3.4 Cardiac Rhythm Management Devices Market, Germany, Volume (Units), 2014-2021 27
3.4.1 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Volume (Units), by Segment, 2007-2014 29
3.4.2 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Volume (Units), by Segment, 2007-2014 31
3.4.3 Pacemakers Market, Germany, Volume (Units), by Segment, 2007-2014 33
3.4.4 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Volume (Units), by Segment, 2014-2021 35
3.4.5 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Volume (Units), by Segment, 2014-2021 37
3.4.6 Pacemakers Market, Germany, Volume (Units), by Segment, 2014-2021 39
3.5 Cardiac Rhythm Management Devices Market, Germany, Average Price ($), 2007-2021 41
3.6 Cardiac Rhythm Management Devices Market, Germany, Distribution Share by Revenue ($m), 2013-2014 43
3.7 Cardiac Rhythm Management Devices Market, Germany, Company Share by Revenue ($m), 2014 44
Check Discount on this report @ https://www.wiseguyreports.com/check_discount/417107/germany-cardiac-rhythm-management-devices-market-outlook
4 Overview of Key Companies in Germany, Cardiac Rhythm Management Devices Market 46
4.1 Medtronic plc 46
4.1.1 Company Overview 46
4.2 St. Jude Medical, Inc. 46
4.2.1 Company Overview 46
4.3 Boston Scientific Corporation 46
4.3.1 Company Overview 46
4.4 Biotronik SE & Co. KG 47
4.4.1 Company Overview 47
4.5 Sorin S.p.A. (Inactive) 47
4.5.1 Company Overview 47
5 Cardiac Rhythm Management Devices Market Pipeline Products 48
6 Recent Developments 49
6.1 Corporate Communications 49
6.1.1 Nov 16, 2015: Konica Minolta to Start In Vitro Diagnostics Business in European and American Markets: SPFS Immunoassay System on Reference Exhibit at MEDICA 2015 in Germany 49
6.2 Other Significant Developments 50
6.2.1 Dec 04, 2015: BIOTRONIK and Cardiology Experts Support Heartbeat International in Top Education 50
6.2.2 Feb 19, 2015: Helius Medical Enrols First Patients In Multiple Sclerosis Feasibility Trial Of PoNS Device 51
Check Discount on this report @ https://www.wiseguyreports.com/check_discount/417107/germany-cardiac-rhythm-management-devices-market-outlook
6.3 Product News 52
6.3.1 Dec 22, 2015: FDA Approves BIOTRONIK Iperia ICD Systems with Full-Body ProMRI Technology 52
6.4 Strategy And Business Planning 53
6.4.1 May 14, 2015: Merrimack Pharmaceuticals Announces Presentations on MM-398 at the 2015 American Society of Clinical Oncology Annual Meeting 53
7 Appendix 55
7.1 Research Methodology 56
7.1.1 Coverage 56
7.1.2 Secondary Research 56
7.1.3 Primary Research 57
7.1.4 Market Modeling and Forecasting 58
7.1.5 Company Share Analysis 61
7.1.6 Distribution Share Analysis 62
7.2 Expert Panel 63
7.3 GlobalData Consulting 63
7.4 Contact Us 63
7.5 Disclaimer 63
6.3.1 Dec 22, 2015: FDA Approves BIOTRONIK Iperia ICD Systems with Full-Body ProMRI Technology 52
6.4 Strategy And Business Planning 53
6.4.1 May 14, 2015: Merrimack Pharmaceuticals Announces Presentations on MM-398 at the 2015 American Society of Clinical Oncology Annual Meeting 53
7 Appendix 55
7.1 Research Methodology 56
7.1.1 Coverage 56
7.1.2 Secondary Research 56
7.1.3 Primary Research 57
7.1.4 Market Modeling and Forecasting 58
7.1.5 Company Share Analysis 61
7.1.6 Distribution Share Analysis 62
7.2 Expert Panel 63
7.3 GlobalData Consulting 63
7.4 Contact Us 63
7.5 Disclaimer 63
Contact US:
NORAH TRENT
Partner Relations &
Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
No comments:
Post a Comment